Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SQZ Biotechnologies Co's quarterly market cap
declined
from Mar. 2023 ($16.51 Mil) to Jun. 2023 ($7.96 Mil) and
declined
from Jun. 2023 ($7.96 Mil) to Sep. 2023 ($2.37 Mil).
SQZ Biotechnologies Co's annual market cap
declined
from Dec. 2020 ($718.30 Mil) to Dec. 2021 ($251.23 Mil) and
declined
from Dec. 2021 ($251.23 Mil) to Dec. 2022 ($21.82 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SQZ Biotechnologies Co's Enterprise Value for Today is $0.71 Mil.
SQZ Biotechnologies Co (OTCPK:SQZB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, SQZ Biotechnologies Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SQZ Biotechnologies Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SQZ Biotechnologies Co's Market Cap distribution charts can be found below:
* The bar in red indicates where SQZ Biotechnologies Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
SQZ Biotechnologies Co's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SQZ Biotechnologies Co (SQZB) has a Market Cap of $0.71 Mil as of Jul. 31, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SQZ Biotechnologies Co and its competitors.
Is SQZ Biotechnologies Co's Market Cap too high?
SQZ Biotechnologies Co's current Market Cap is $0.71 Mil. The Biotechnology industry median Market Cap is 110.32. SQZ Biotechnologies Co's value of $0.71 Mil is 99.4% below this industry median. Overall, SQZ Biotechnologies Co has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SQZ Biotechnologies Co's Market Cap compare to AGTX and ISCO?
SQZ Biotechnologies Co's Market Cap of $0.71 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 110.32. SQZ Biotechnologies Co's value of $0.71 Mil is 99.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 110.32, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SQZ Biotechnologies Co's current Market Cap of $0.71 Mil is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SQZ Biotechnologies Co and its competitors. For the Biotechnology industry, the median Market Cap is 110.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SQZ Biotechnologies Co's current Market Cap is $0.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SQZ Biotechnologies Co stock overvalued right now?
SQZ Biotechnologies Co (SQZB) has a current Market Cap of $0.71 Mil. The current Market Cap is $0.71 Mil and 99.4% below the Biotechnology industry median of 110.32. SQZ Biotechnologies Co's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For SQZ Biotechnologies Co (SQZB), the current Market Cap is $0.71 Mil as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
12GF Score
Get the complete analysis for SQZB
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SQZB has been successfully added to your 
